http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63215686-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-301 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30 |
| filingDate | 1987-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1f6a931a6626138a5833628c96c268a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e2738244d3287aacf1a42d32fb1a16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d777f4d04981d4b8f9853b5c7b9fe9f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6544781b5c8ebc5411f32862ae4b5f35 |
| publicationDate | 1988-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S63215686-A |
| titleOfInvention | Aminoethylphosphinic acid derivative |
| abstract | NEW MATERIAL:A compound expressed by formula I (X represents H, amino acid reside which may contain protecting group, etc.; Y represents H, alkylacyl which may be substituted, etc.; R 1 and R 2 represent H or alkyl). n EXAMPLE: (1-Aminoethyl)(2-L-methionylamino-2-carboxyethyl)phosphinic acid. n USE: An antimicrobial agent useful for treating various types of infectious diseases. n PREPARATION: For example, phosphinic acids expressed by formula II (W represents amino-protecting group) are reacted with trimethylsilyl chloride in the presence of triethyl amine to afford a silyl ester intermediate expressed by formula III. On the other hand, a chloroalanine derivative expressed by formula IV (Y' represents protecting group-containing amino acid residue or protecting group-containing oligopeptide residue; R represents alkyl) is reacted with triethylamine to afford dehydroalanines expressed by formula V. Then the compound expressed by formula III is added to the compounds expressed by formula V and the product is brought into contact with water. n COPYRIGHT: (C)1988,JPO&Japio |
| priorityDate | 1987-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.